Medium-chain acyl-coenzyme A dehydrogenase deficiency
Other Names for this Disease
- ACADM deficiency
- Acyl-CoA dehydrogenase medium chain deficiency of
- MCAD deficiency
- MCADH deficiency
Your QuestionMy daughter had newborn screening performed at the hospital after her birth. Her doctor recently called to tell us that her test came back abnormal for medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency. Are there factors that may contribute to a falsely positive result?
We have identified the following information that we hope you find helpful. If you still have questions, please contact us.
Questions on this page
- What is medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency?
- What are the signs and symptoms of medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency?
- How is medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD) diagnosed?
- What is newborn screening?
- Are there factors which can cause a false positive test result for medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency on newborn screen?
- What follow-up testing can be done to definitively determine if my child has medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency?
Newborn screening tests look for serious developmental, genetic, and metabolic disorders so that important action can be taken during the critical time before symptoms develop. Screening tests do not diagnose illnesses. They identify which babies need additional testing to confirm or rule out illnesses. Good screening tests have a low false-negative rate (if the test is normal, the child should be healthy), but may have a high false-positive rate (as many affected children as possible should test positive, even if this means many healthy children also test positive).
An abnormal result on a newborn screen means that the child should have additional testing to confirm or rule out the condition. If a disorder is diagnosed on follow-up testing, appropriate treatment can be started right away, before symptoms appear.
The false positive rate for medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency varies between screening programs because of differences in acylcarnitine analysis and profiling. Programs that screen for MCAD deficiency but not other fatty acid oxidation disorders often limit their analysis to octanoylcarnitine, the predominant marker for MCAD deficiency. However, octanoylcarnitine is not specific for MCAD deficiency and is expected to be elevated in several other disorders (i.e., medium-/short-chain 3-hydroxy acyl-CoA dehydrogenase deficiency, medium-chain 3-keto acyl-CoA thiolase deficiency, glutaric acidemia type II) and in newborns treated with valproate or fed a diet rich in medium-chain triglycerides. Consideration disorders included in the differential diagnosis should minimize the false positive rate.
Follow-up testing can be ordered by your daughter's pediatrician or through a genetics clinic. Genetics clinics are a source of information for individuals and families regarding genetic diagnosis, natural history, treatment, mode of inheritance, and genetic risks to other family members. To find a genetics clinic, we recommend that you contact your primary doctor for a referral. Click here to learn more about genetic consultations.
The following online resources can also help you find a genetics professional in your community:
* GeneTests - A searchable directory of US and international genetics and prenatal diagnosis clinics. Go to the following link and click on 'Clinic Directory' to find a genetic service close to you.
* ResourceLink - A database of genetics counseling services, searchable by location, name, institution, type of practice, or specialty. Hosted by the National Society of Genetic Counselors.
* Genetic Centers, Clinics, and Departments - A comprehensive resource list for genetic counseling, including links to genetic centers and clinics, associations, and university genetics departments. Hosted by the University of Kansas Medical Center.
- Medium-chain acyl-coenzyme A dehydrogenase deficiency. Genetics Home Reference (GHR). 2009; http://ghr.nlm.nih.gov/condition=mediumchainacylcoenzymeadehydrogenasedeficiency. Accessed 2/4/2011.
- Simon Olpin. Medium chain acyl-CoA dehydrogenase deficiency. Orphanet. February, 2014; http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=EN&Expert=42. Accessed 7/7/2014.
- Greene A, O'Reilly D. Newborn screening tests. MedlinePlus. September 6, 2007; http://www.nlm.nih.gov/medlineplus/ency/article/007257.htm. Accessed 11/10/2008.
- Matern D, Rinaldo P. Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency. GeneReviews. February 3, 2005; http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=mcad#mcad. Accessed 2/4/2011.